| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/29/2010 | US20100105627 Pharmaceutical compositions and related methods of delivery |
| 04/29/2010 | US20100104644 Compositions and Methods for Treating or Preventing Ophthalmic Disease |
| 04/29/2010 | US20100104551 Method for prolonging activity of autodegradable enzymes and compositions thereof |
| 04/29/2010 | US20100104516 Use of flagellin to prevent and treat gram negative bacterial infection |
| 04/29/2010 | CA2751761A1 Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor |
| 04/29/2010 | CA2741288A1 Ophthalmic compositions useful for improving visual acuity |
| 04/29/2010 | CA2740952A1 Compounds for treating ophthalmic diseases and disorders |
| 04/28/2010 | EP2179997A1 Sulfonamide compound, and crystal thereof |
| 04/28/2010 | EP2179736A1 Two-component eye drops containing pirenoxine |
| 04/28/2010 | EP2178549A1 Antimicrobial peptide, compositions , and methods of use |
| 04/28/2010 | EP2178535A1 Compositions and methods for modulating endophthalmitis using fluoroquinolones |
| 04/28/2010 | EP2178504A2 Preservative-free prostaglandin-based ophthalmic solution |
| 04/28/2010 | EP1472225B1 2-piperazine-pyridines useful for treating pain |
| 04/28/2010 | EP1420785B1 Substituted indeno [1,2-c]isoquinoline derivatives and methods of use thereof |
| 04/28/2010 | EP1363640B1 Nucleic acid derivatives |
| 04/28/2010 | CN1761686B Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 04/28/2010 | CN1678333B Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease |
| 04/28/2010 | CN1596266B Specific binding agents of human angiopoietin-2 |
| 04/28/2010 | CN1524579B Composite viscoelastic preparation |
| 04/28/2010 | CN101698026A Traditional Chinese medicine formula for treating eye disease of amblyopia and method for producing preparation thereof |
| 04/28/2010 | CN101697795A Health beverage |
| 04/28/2010 | CN101014560B Wikstroemia indeca extract, their production and use in the production of anti-inflammatory pharmaceutical |
| 04/27/2010 | US7705125 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 04/27/2010 | US7705124 Leucine-based motif and clostridial neurotoxins |
| 04/27/2010 | US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer |
| 04/27/2010 | US7704943 Angiogenesis inhibitors; using transglutaminase; antitumor agents; anticancer agents |
| 04/22/2010 | WO2010045395A2 Curcumin analog compositions and related methods |
| 04/22/2010 | WO2010045276A2 Azabenzimidazolones |
| 04/22/2010 | WO2009151644A3 Small molecule inhibitors of autotaxin methods of use |
| 04/22/2010 | WO2009151561A3 Methods and compounds for antimicrobial intervention |
| 04/22/2010 | WO2009100438A3 Compounds that enhance atoh-1 expression |
| 04/22/2010 | US20100099771 Use of cooling agents to relieve mild ocular irritation and enhance comfort |
| 04/22/2010 | US20100099770 Method for treating diabetic peripheral neuropathic pain |
| 04/22/2010 | US20100099714 AMPA and NMDA Receptor Antagonists for Neurodegenerative Diseases |
| 04/22/2010 | US20100099662 Hydrazone derivative |
| 04/22/2010 | US20100099655 Implants and methods for treating inflammation-mediated conditions of the eye |
| 04/22/2010 | US20100099629 Ophthalmological composition |
| 04/22/2010 | US20100099611 Anti-angiogenic peptides |
| 04/22/2010 | US20100098772 Drug delivery systems and methods for treating neovascularization |
| 04/22/2010 | US20100098727 Methods for treating eye disorders |
| 04/22/2010 | US20100098692 Humanized Endoglin Antibodies |
| 04/21/2010 | EP2177620A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/21/2010 | EP2177530A1 Octapeptide having antiangiogenic activity |
| 04/21/2010 | EP2177513A1 Phenylacetic acid compound |
| 04/21/2010 | EP2175858A1 Pharmaceutical compositions and methods of treating dry eye disorders |
| 04/21/2010 | EP1610780B1 Cyclic protein tyrosine kinase inhibitors |
| 04/21/2010 | EP1479670B1 Novel fused ring indazole compounds |
| 04/21/2010 | EP1272175B1 N,n'-diaryl guanidines as il-8 receptor antagonists |
| 04/21/2010 | CN1740169B Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/21/2010 | CN101695554A Chinese medicament for treating myopia |
| 04/21/2010 | CN101695540A Chinese medicament for treating cataract |
| 04/21/2010 | CN101695530A Medicament for treating myopia and preparation method thereof |
| 04/21/2010 | CN101695505A Preparation method of enzyme hydrolysis pearl powder |
| 04/21/2010 | CN101695504A Preparation method of nanometer pearl powder |
| 04/21/2010 | CN101695495A Composition for treatment of external secretion disorders |
| 04/21/2010 | CN101167710B Chloromycetin eyedrops with long quality guaranteed period and preparation method thereof |
| 04/20/2010 | US7700657 Vitamin D analogs |
| 04/20/2010 | US7700635 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitorsfor seine/threonine kinases, phosphatases; Alzheimer's |
| 04/20/2010 | US7700586 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 04/20/2010 | US7700562 Use of —furin—“convertase” inhibitors in the treatment of fibrosis and scarring |
| 04/20/2010 | US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides |
| 04/20/2010 | US7700557 for treating diseases relating to angiogenesis; fusion protein possesses ribosome inactivating activity and ability to bind to cellular vascular endothelial growth factor (VEGF) receptors |
| 04/20/2010 | US7700368 plant extracts; obtaining ethanolic solution, passing through column of activated charcoal, and collecting the eluate, removing solvent by rotary evaporation, redissolving in methanol, filtering |
| 04/20/2010 | US7700271 Method of diagnosis and treatment and agents useful for same |
| 04/20/2010 | US7700085 Administering an agent which inhibits binding of advanced glycation endproducts to any of their receptors; wound healing |
| 04/20/2010 | US7700077 comprising from 1300 to 1500 mg/l of Na+, from 4500 to 6500 mg/l of K+, from 50 to 1300 mg/l of Mg++, from 20 to 350 mg/l of ca++, from 4000 to 6000 mg/l of Cl-, a pH of from 4-9, and an osmolality of from 150-700 mOsm/kg; for treating and cleaning the eye |
| 04/20/2010 | CA2438506C Use of a cyclohexenone derivatives in the manufacture of a medicament for treating diabetic complications |
| 04/20/2010 | CA2419880C 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1h)one derivatives |
| 04/20/2010 | CA2348741C Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use |
| 04/15/2010 | WO2010042886A2 Pyrone analogs for therapeutic treatment |
| 04/15/2010 | WO2010042843A2 Composition and method for treating dry eye syndrome |
| 04/15/2010 | WO2010041711A1 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
| 04/15/2010 | WO2010041618A1 Pharmaceutical composition for prevention or treatment of hearing loss and secondary symptoms of hearing loss |
| 04/15/2010 | WO2010040232A1 Use of scyllo-inositols for the treatment of macular degeneration-related disorders |
| 04/15/2010 | WO2010021680A3 Inhibitors of beta-secretase |
| 04/15/2010 | WO2010018837A3 Protein cross-linking inhibitor |
| 04/15/2010 | WO2010018836A3 Polyglutamine aggregation inhibitor |
| 04/15/2010 | WO2009106767A3 Use of a homeoprotein of the bicoid family for preventing or treating retinal ganglionic neurone degeneration |
| 04/15/2010 | WO2009071753A8 4-phenyl-1,3-thiazole and 4-phenyl-1,3-oxazole derivatives as cannabinoid receptor ligands |
| 04/15/2010 | US20100093865 Sulphur-linked compounds for treating ophthalmic diseases and disorders |
| 04/15/2010 | US20100093858 Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye drops |
| 04/15/2010 | US20100093853 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
| 04/15/2010 | US20100093845 Composition and method for treating dry eye syndrome |
| 04/15/2010 | US20100093809 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds |
| 04/15/2010 | US20100093790 Isoquinoline compounds |
| 04/15/2010 | US20100093789 Sulfonamide compound |
| 04/15/2010 | US20100093770 Therapeutic agent for glaucoma containing adenosine derivative as active ingredient |
| 04/15/2010 | US20100093739 Method for decreasing capillary permeability in the retina |
| 04/15/2010 | US20100093708 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 04/15/2010 | US20100093671 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 04/15/2010 | US20100093648 Treatment of macular degeneration-related disorders |
| 04/15/2010 | US20100092542 Compositions and methods for treatment of eye disorders |
| 04/15/2010 | US20100092452 Replenishment and Enrichment of Ocular Surface Lubrication |
| 04/15/2010 | DE102008050597A1 Preparation, useful for treating and preventing idiopathic sudden sensorineural hearing loss, comprises pentaerythritol tetra-, pentaerythritol trinitrate, pentaerythritol dinitrate or pentaerythritol mononitrate, and an excipient |
| 04/15/2010 | CA2740124A1 Use of scyllo-inositols for the treatment of macular degeneration-related disorders |
| 04/15/2010 | CA2740003A1 Pyrone analogs for therapeutic treatment |
| 04/15/2010 | CA2739658A1 Composition and method for treating dry eye syndrome |
| 04/14/2010 | EP2174949A2 Leucine-based motif and clostridial neurotoxins |
| 04/14/2010 | EP2174667A1 Agent for treatment of ophthalmia containing interleukin-6 receptor inhibitor as active ingredient |
| 04/14/2010 | EP2174659A1 Substituted indeno[1,2-c]isoquinoline derivatives and uses thereof |